# OnCo record paper-planchard-dabrafenib-trametinib-braf-nsclc-lancet-oncol-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-planchard-dabrafenib-trametinib-braf-nsclc-lancet-oncol-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-planchard-dabrafenib-trametinib-braf-nsclc-lancet-oncol-2016" ;
  schema:name "Dabrafenib plus trametinib in previously treated BRAF V600E-mutant metastatic non-small-cell lung cancer"@en ;
  schema:description "Combining a BRAF inhibitor with a MEK inhibitor shrank tumours in about two thirds of previously treated patients with BRAF V600E-mutant lung cancer, far more than BRAF inhibition alone, leading to the first approval for this driver."@en ;
  schema:url <https://onco.cc/key-papers/paper-planchard-dabrafenib-trametinib-braf-nsclc-lancet-oncol-2016/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(16)30146-2>, <https://pubmed.ncbi.nlm.nih.gov/27283860/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(16)30146-2> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Planchard D, Besse B, Groen HJM, et al." ;
  onco:cancers <https://onco.cc/cancers/braf-v600e-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/dabrafenib/>, <https://onco.cc/drugs/trametinib/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .